Bringing the fundamentals into focus…
Back to Ascendis Pharma A/S
How Ascendis Pharma A/S stacks up
ASND · against 1,216 other Healthcare companies
Growth
96/ 100
Near the top of its peers.
Ranked #39 of 1,217 · scores higher than 96% of peers
Bars: peers in each 10-point band of the growth score128 peers with a growth score of 90–100, including ASND · Click a bar to see the companies
Why growth scores 96?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over the last year: stronger than 95% of peers. Revenue growth: 98.0% vs peer median 6.1%
- faster revenue growth over three years: stronger than 98% of peers. 3-year revenue growth: 141.4% vs peer median 5.8%
Metric by metric
Position: dot = ASND, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ASND | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 98.0% | 6.1% | 95% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 141.4% | 5.8% | 98% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around ASND| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 32 | 4.4B AUD (≈$2.9B) | 97 | 51 | |
| 39 | 534.0B KRW (≈$385M) | 96 | 59 | |
| 39 | 10.8B JPY (≈$73M) | 96 | 27 | |
| 39 | 56.7B USD | 96 | 79 | |
| 39 | 16.5B USD | 96 | 37 | |
| 39 | 377M USD | 96 | 29 | |
| 39 | 14.5B USD | 96 | 30 | |
| 39 | 5.7B USD | 96 | 52 | |
| 39 | 500M USD | 96 | 63 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score